Page 741 - Coronavirus Vaccine

Maharashtra: 562 fresh Covid-19 cases in Thane, 12 more fatalities

The Covid-19 tally in Maharashtra's Thane district has gone up to 234,347 with the addition of 562 new cases, an official said

Pune's Gennova gets nod for clinical trials of India's first mRNA vaccine

DCGI granted conditional approval for phase 1 and 2 clinical trials of Gennova's mRNA based Covid-19 vaccine candidate

Bengal reports 47 more deaths due to Covid-19, 2,956 additional cases

West Bengal's Covid-19 death toll rose 8,867 after 47 more people succumbed to the disease, the health department said in a bulletin

India's first mRNA Covid-19 vaccine gets nod to start phase 1 trials

The Central Drugs Standard Control Organisation permitted Pune-based Gennova Biopharmaceuticals to conduct Phase 1/2 clinical trials for its mRNA Covid-19 vaccine candidate

Top headlines: Sensex on record high; regulations for streaming industry

From Sensex crossing 46,000 amid record FPI flows to Sterling & Wilson eyeing 50 Gw of projects in renewable energy space, here are top headlines this morning

South Africa declares second wave of coronavirus infection as cases surge

South Africa has declared a second wave of coronavirus as the number of cases surged with the per day infections exceeding 6,000

Pfizer-BioNTech Covid-19 vaccine data hacked from European Medicines Agency

German company BioNTech and US pharmaceutical company Pfizer say data on their coronavirus vaccine were unlawfully accessed during a cyberattack on the servers of the European Medicines Agency

Covid-19 vaccination campaign to begin on Dec 27: Israel PM Netanyahu

PM Benjamin Netanyahu has announced that Israel will begin vaccinating the public against the coronavirus on Dec 27, making it one of the first countries in the world to innoculate its citizens

Curbs may have to be maintained after vaccination: Ramanan Laxminarayan

Laxminarayan, in an interview with Geetika Srivastava, says that masks and small gatherings may stick around for a while

Review panel asks vaccine makers to submit more data to get authorisation

Experts ask Bharat Biotech for phase 3 data, Serum's UK approval status

Oil prices near $50 as coronavirus vaccine fuels demand recovery hopes

Brent crude rose 51 cents, or 1 per cent, to $49.35 a barrel by 7:35 pm IST. West Texas Inter-mediate (WTI) crude climbed 51 cents, up 1 per cent, to $49.35

Covid-19 vaccine: Joe Biden vows 100 million shots in first 100 days

Biden has promised to distribute a coronavirus vaccine to 100 million people during the first three months of his incoming administration, pledging 100 million shots in the first 100 days

UAE says Chinese coronavirus vaccine 86% effective, offers few details

The United Arab Emirates said Wednesday a Chinese coronavirus vaccine tested in the federation of sheikhdoms is 86 per cent effective, though it released few details. The UAE, home to Dubai and Abu Dhabi, conducted a trial involving 31,000 volunteers from 125 nations. Volunteers between 18 and 60 years old received two doses of the vaccine over 28 days. The UAE's Health and Prevention Ministry announced the results via a statement on the state-run WAM news agency, saying they have reviewed Sinopharm CNBG's interim analysis of the Phase III trials. The analysis shows no serious safety concerns, the statement said. It wasn't immediately clear if the announced results included only those taking part in the testing in the UAE or if they also include results from China and elsewhere. The statement described the vaccine as receiving official registration without elaborating on what that meant. Emirati officials could not be immediately reached for comment. The Sinopharm vaccine has been

UK asks those with severe allergies to skip Pfizer jab after 2 reactions

Starting with the elderly and frontline workers, Britain began mass vaccinating its population on Tuesday

Provide more safety data on Covid-19 vaccine: SEC to Serum, Bharat Biotech

The application submitted by the Pfizer was not discussed at the SEC meeting as the company has requested for more time for giving its presentation

Gennova Pharma gets conditional permission for human trial of Covid vaccine

DCGI granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Vaccine, financial relief near as coronavirus ravages US health, economy

The chief advisor to the Trump administration's Operation Warp Speed vaccine development program said the first US injection could happen on Sunday or Monday

Pfizer Covid-19 vaccine to have differential pricing across countries

The company's Indian arm has sought emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine against Covid-19 in the country from the Indian drug regulator.

Trust DCGI to ask for enough data before vaccine approval: Gagandeep Kang

Having achieved the first goal of seeing whether the vaccines work, we can be more ambitious and design studies to assess whether and how much they reduce transmission, says Kang